| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 3853483 | Diálisis y Trasplante | 2008 | 7 Pages | 
Abstract
												The present study suggests that antiplatelet therapy may be an important factor in determining erythropoietin requirements in HD patients.
											Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Nephrology
												
											Authors
												Antonio Gascón, Rafael Virto, Luis Miguel Lou, Raquel Pernaute, Rosario Moreno, Jesús Pérez, MarÃa José Aladrén, Elena Castillón, Belén Moragrega, Ricardo Gómez, Pedro José Vives, Rafael Álvarez, Francisco Javier GarcÃa-Labat, 
											